$DOC
HEALTHPEAK PROPERTIES, INC. Stock $doc

$doc Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000162828023014190 Filed on April 28, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$545.4M	$525.7M
YoY Change	5.31%	5.48%
Cost Of Revenue	$221.3M	$223.1M
YoY Change	2.89%	7.64%
Gross Profit	$324.2M	$302.6M
YoY Change	7.03%	3.94%
Gross Profit Margin	59.43%	57.56%
Selling, General & Admin	$25.94M	$24.55M
YoY Change	4.66%	3.0%
% of Gross Profit	8.0%	8.11%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$197.6M	$179.2M
YoY Change	9.47%	0.84%
% of Gross Profit	60.95%	59.23%
Operating Expenses	$223.5M	$223.1M
YoY Change	3.94%	7.64%
Operating Profit	$100.7M	$79.50M
YoY Change	14.6%	-5.22%
Interest Expense	-$49.07M	$47.96M
YoY Change	-217.21%	27.61%
% of Operating Profit	-48.75%	60.33%
Other Income/Expense, Net	$1.364M	$82.35M
YoY Change	-89.67%	271.41%
Pretax Income	$54.61M	$133.0M
YoY Change	-19.93%	80.41%
Income Tax	$1.136M	$302.0K
% Of Pretax Income	2.08%	0.23%
Net Earnings	$51.75M	$119.0M
YoY Change	-24.27%	66.1%
Net Earnings / Revenue	9.49%	22.63%
Basic Earnings Per Share	$0.09	$0.22
Diluted Earnings Per Share	$0.09	$0.22
COMMON SHARES
Basic Shares Outstanding	547.0M shares	546.8M shares
Diluted Shares Outstanding	547.3M shares	547.1M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$103.8M	$59.24M
YoY Change	42.14%	-33.49%
Cash & Equivalents	$103.8M	$59.24M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$53.47M	$57.71M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$157.2M	$116.9M
YoY Change	30.65%	-18.32%
LONG-TERM ASSETS
Property, Plant & Equipment	$13.33B	$13.32B
YoY Change	1.71%	1.92%
Goodwill
YoY Change
Intangibles	$364.5M	$392.0M
YoY Change	-22.6%	-21.15%
Long-Term Investments	$732.0M	$714.7M
YoY Change	82.01%	77.27%
Other Assets	$65.03M	$57.99M
YoY Change	-46.46%	-32.5%
Total Long-Term Assets	$15.45B	$15.49B
YoY Change	1.63%	2.25%
TOTAL ASSETS
Total Short-Term Assets	$157.2M	$116.9M
Total Long-Term Assets	$15.45B	$15.49B
Total Assets	$15.60B	$15.60B
YoY Change	1.86%	2.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$682.8M	$689.0M
YoY Change	226.39%	220.31%
Accrued Expenses	$204.5M	$207.7M
YoY Change	-51.73%	-48.46%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$87.47M	$88.77M
YoY Change	3342.38%	2249.52%
Total Short-Term Liabilities	$887.3M	$896.7M
YoY Change	39.65%	44.19%
LONG-TERM LIABILITIES
Long-Term Debt	$6.569B	$6.454B
YoY Change	1.82%	1.93%
Other Long-Term Liabilities	$1.022B	$1.028B
YoY Change	-19.87%	-20.18%
Total Long-Term Liabilities	$7.591B	$7.482B
YoY Change	-1.76%	-1.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$887.3M	$896.7M
Total Long-Term Liabilities	$7.591B	$7.482B
Total Liabilities	$9.068B	$8.379B
YoY Change	8.45%	1.66%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$547.1M	$547.0M
YoY Change	1.38%	1.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.535B	$6.610B
YoY Change
Total Liabilities & Shareholders Equity	$15.60B	$15.60B
YoY Change	1.86%	2.06%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	$51.75M	$119.0M
YoY Change	-24.27%	66.1%
Depreciation, Depletion And Amortization	$197.6M	$179.2M
YoY Change	9.47%	0.84%
Cash From Operating Activities	$297.8M	$173.9M
YoY Change	16.57%	-10.43%
INVESTING ACTIVITIES
Capital Expenditures	$194.8M	$215.1M
YoY Change	-191.35%	-168.87%
Acquisitions
YoY Change
Other Investing Activities	-$211.0K	$271.5M
YoY Change	-88.99%	308.88%
Cash From Investing Activities	-$195.0M	$56.35M
YoY Change	-9.37%	-122.91%
FINANCING ACTIVITIES
Cash Dividend Paid		$165.0M
YoY Change		0.94%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-59.50M	-$239.9M
YoY Change	11.07%	1195.85%
NET CHANGE
Cash From Operating Activities	297.8M	$173.9M
Cash From Investing Activities	-195.0M	$56.35M
Cash From Financing Activities	-59.50M	-$239.9M
Net Change In Cash	43.30M	-$9.609M
YoY Change	-426.55%	-86.33%
FREE CASH FLOW
Cash From Operating Activities	$297.8M	$173.9M
Capital Expenditures	$194.8M	$215.1M
Free Cash Flow	$103.0M	-$41.19M
YoY Change	-78.02%	-108.13%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000765880
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-08895
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Healthpeak Properties, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-0091377
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	4600 South Syracuse Street
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 500
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Denver
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80237
CY2023Q1	dei	City Area Code CityAreaCode	720
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	428-5050
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $1.00 par value
CY2023Q1	dei	Trading Symbol TradingSymbol	PEAK
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	546995686	shares
CY2023Q1	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	12889290000	usd
CY2022Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	12784078000	usd
CY2023Q1	us-gaap	Development In Process DevelopmentInProcess	819810000	usd
CY2022Q4	us-gaap	Development In Process DevelopmentInProcess	760355000	usd
CY2023Q1	us-gaap	Land Land	2674942000	usd
CY2022Q4	us-gaap	Land Land	2667188000	usd
CY2023Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	3296781000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	3188138000	usd
CY2023Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	13087261000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	13023483000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	6152000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	8280000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	243149000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	374832000	usd
CY2023Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	714679000	usd
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	706677000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2413000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2399000	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	57705000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	53436000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59235000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	72032000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	57990000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	54802000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	391956000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	418061000	usd
CY2023Q1	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	0	usd
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	49866000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	235591000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	237318000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	754723000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	780722000	usd
CY2023Q1	us-gaap	Assets Assets	15602289000	usd
CY2022Q4	us-gaap	Assets Assets	15771229000	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	556000000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	995606000	usd
CY2023Q1	us-gaap	Loans Payable To Bank LoansPayableToBank	496168000	usd
CY2022Q4	us-gaap	Loans Payable To Bank LoansPayableToBank	495957000	usd
CY2023Q1	us-gaap	Unsecured Debt UnsecuredDebt	5056543000	usd
CY2022Q4	us-gaap	Unsecured Debt UnsecuredDebt	4659451000	usd
CY2023Q1	us-gaap	Secured Debt SecuredDebt	345167000	usd
CY2022Q4	us-gaap	Secured Debt SecuredDebt	346599000	usd
CY2023Q1	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	149604000	usd
CY2022Q4	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	156193000	usd
CY2023Q1	peak	Liabilities Related To Assets Held For Sale Net LiabilitiesRelatedToAssetsHeldForSaleNet	0	usd
CY2022Q4	peak	Liabilities Related To Assets Held For Sale Net LiabilitiesRelatedToAssetsHeldForSaleNet	4070000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	207734000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	208515000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	688994000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	772485000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	878444000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	844076000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	8378654000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	8482952000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	85902000	usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	105679000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	546994803	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	546994803	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	546641973	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	546641973	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	546995000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	546642000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10360058000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10349614000	usd
CY2023Q1	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	4316038000	usd
CY2022Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	4269689000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	18721000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	28134000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	6609736000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	6654701000	usd
CY2023Q1	us-gaap	Minority Interest In Joint Ventures MinorityInterestInJointVentures	320363000	usd
CY2022Q4	us-gaap	Minority Interest In Joint Ventures MinorityInterestInJointVentures	327721000	usd
CY2023Q1	us-gaap	Minority Interest In Preferred Unit Holders MinorityInterestInPreferredUnitHolders	207634000	usd
CY2022Q4	us-gaap	Minority Interest In Preferred Unit Holders MinorityInterestInPreferredUnitHolders	200176000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	527997000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	527897000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7137733000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7182598000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15602289000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15771229000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	392431000	usd
CY2022Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	370150000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	127084000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	121560000	usd
CY2023Q1	us-gaap	Interest Income Operating InterestIncomeOperating	6163000	usd
CY2022Q1	us-gaap	Interest Income Operating InterestIncomeOperating	5494000	usd
CY2023Q1	us-gaap	Direct Financing Lease Revenue DirectFinancingLeaseRevenue	0	usd
CY2022Q1	us-gaap	Direct Financing Lease Revenue DirectFinancingLeaseRevenue	1168000	usd
CY2023Q1	us-gaap	Revenues Revenues	525678000	usd
CY2022Q1	us-gaap	Revenues Revenues	498372000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	47963000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	37586000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	179225000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	177733000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	223088000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	207247000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24547000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23831000	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2425000	usd
CY2022Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	296000	usd
CY2023Q1	peak	Impairments And Allowance For Credit Loss Reserves Recoveries Net ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet	-2213000	usd
CY2022Q1	peak	Impairments And Allowance For Credit Loss Reserves Recoveries Net ImpairmentsAndAllowanceForCreditLossReservesRecoveriesNet	132000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	475035000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	446825000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	81578000	usd
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	3856000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	772000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	18316000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	82350000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	22172000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	132993000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	73719000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	302000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	777000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1816000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2084000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	134507000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	75026000	usd
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	usd
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	317000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	134507000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	75343000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	15555000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	3730000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	118952000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	71613000	usd
CY2023Q1	peak	Participating Securities Distributed And Undistributed Earnings Loss Basic And Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted	1254000	usd
CY2022Q1	peak	Participating Securities Distributed And Undistributed Earnings Loss Basic And Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted	1976000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	117698000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	69637000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.22
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.13
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.22
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.13
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	546842000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	539352000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	547110000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	539586000	shares
CY2023Q1	us-gaap	Profit Loss ProfitLoss	134507000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	75343000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-9477000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-64000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-100000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-9413000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	100000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	125094000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	75443000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	15555000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	3730000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	109539000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	71713000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7182598000	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	105679000	usd
CY2023Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	134341000	usd
CY2023Q1	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	166000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-9413000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	174000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	6467000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4565000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.30
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	165301000	usd
CY2023Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	22731000	usd
CY2023Q1	peak	Temporary Equity Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders TemporaryEquityNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	72000	usd
CY2023Q1	peak	Temporary Equity Noncontrolling Interest Contributions From Noncontrolling Interest TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest	96000	usd
CY2023Q1	peak	Adjustments Of Permanent Equity To Temporary Equity AdjustmentsOfPermanentEquityToTemporaryEquity	-19967000	usd
CY2023Q1	peak	Temporary Equity Adjustments Of Permanent Equity To Temporary Equity TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity	-19967000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7137733000	usd
CY2023Q1	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	85902000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7058760000	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	87344000	usd
CY2022Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	75331000	usd
CY2022Q1	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	12000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	100000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	329000	usd
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	11352000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6144000	usd
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.30
CY2022Q1	us-gaap	Dividends Common Stock DividendsCommonStock	163780000	usd
CY2022Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	7509000	usd
CY2022Q1	peak	Temporary Equity Noncontrolling Interest Contributions From Noncontrolling Interest TemporaryEquityNoncontrollingInterestContributionsFromNoncontrollingInterest	233000	usd
CY2022Q1	peak	Adjustments Of Permanent Equity To Temporary Equity AdjustmentsOfPermanentEquityToTemporaryEquity	10301000	usd
CY2022Q1	peak	Temporary Equity Adjustments Of Permanent Equity To Temporary Equity TemporaryEquityAdjustmentsOfPermanentEquityToTemporaryEquity	10301000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6947722000	usd
CY2022Q1	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	97890000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	134507000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	75343000	usd
CY2023Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	179225000	usd
CY2022Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	177733000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3287000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4721000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2821000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2689000	usd
CY2023Q1	us-gaap	Straight Line Rent StraightLineRent	747000	usd
CY2022Q1	us-gaap	Straight Line Rent StraightLineRent	11158000	usd
CY2023Q1	peak	Amortization Of Nonrefundable Entrance Fees And Above Below Market Lease Intangibles Net AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet	-25690000	usd
CY2022Q1	peak	Amortization Of Nonrefundable Entrance Fees And Above Below Market Lease Intangibles Net AmortizationOfNonrefundableEntranceFeesAndAboveBelowMarketLeaseIntangiblesNet	-24725000	usd
CY2023Q1	peak	Income Loss From Equity Method Investments Including Discontinued Operations IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations	1816000	usd
CY2022Q1	peak	Income Loss From Equity Method Investments Including Discontinued Operations IncomeLossFromEquityMethodInvestmentsIncludingDiscontinuedOperations	2148000	usd
CY2023Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	185000	usd
CY2022Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	237000	usd
CY2023Q1	peak	Gain Loss On Sale Of Real Estate Under Direct Financing Lease GainLossOnSaleOfRealEstateUnderDirectFinancingLease	0	usd
CY2022Q1	peak	Gain Loss On Sale Of Real Estate Under Direct Financing Lease GainLossOnSaleOfRealEstateUnderDirectFinancingLease	22693000	usd
CY2023Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-402000	usd
CY2022Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-79000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	-2213000	usd
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	132000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	81578000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	3785000	usd
CY2023Q1	us-gaap	Insured Event Gain Loss InsuredEventGainLoss	-529000	usd
CY2022Q1	us-gaap	Insured Event Gain Loss InsuredEventGainLoss	0	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1698000	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1593000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	19949000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	4144000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-15936000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3653000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	173921000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	194183000	usd
CY2023Q1	us-gaap	Payments To Acquire Other Real Estate PaymentsToAcquireOtherRealEstate	10219000	usd
CY2022Q1	us-gaap	Payments To Acquire Other Real Estate PaymentsToAcquireOtherRealEstate	134067000	usd
CY2023Q1	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	204889000	usd
CY2022Q1	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	178285000	usd
CY2023Q1	us-gaap	Payments For Leasing Costs Commissions And Tenant Improvements PaymentsForLeasingCostsCommissionsAndTenantImprovements	22789000	usd
CY2022Q1	us-gaap	Payments For Leasing Costs Commissions And Tenant Improvements PaymentsForLeasingCostsCommissionsAndTenantImprovements	22839000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	141559000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	13265000	usd
CY2023Q1	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	9640000	usd
CY2022Q1	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	1486000	usd
CY2023Q1	peak	Distributions In Excess Of Earnings From Unconsolidated Joint Ventures DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures	3210000	usd
CY2022Q1	peak	Distributions In Excess Of Earnings From Unconsolidated Joint Ventures DistributionsInExcessOfEarningsFromUnconsolidatedJointVentures	3875000	usd
CY2023Q1	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	2650000	usd
CY2022Q1	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	0	usd
CY2023Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	158381000	usd
CY2022Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	75435000	usd
CY2023Q1	peak	Payments To Acquire Loans Receivable And Other PaymentsToAcquireLoansReceivableAndOther	1918000	usd
CY2022Q1	peak	Payments To Acquire Loans Receivable And Other PaymentsToAcquireLoansReceivableAndOther	1860000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	56345000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-245962000	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	3372255000	usd
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	3732668000	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	3811861000	usd
CY2022Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	3567830000	usd
CY2023Q1	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	399532000	usd
CY2022Q1	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	0	usd
CY2023Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	1325000	usd
CY2022Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	1270000	usd
CY2023Q1	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	4175000	usd
CY2022Q1	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2023Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	-151000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	-4000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6467000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	11352000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	164976000	usd
CY2022Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	163447000	usd
CY2023Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	22803000	usd
CY2022Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	7509000	usd
CY2023Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	96000	usd
CY2022Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	233000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-239875000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-18511000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9609000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-70290000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	126834000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	219448000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	117225000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	149158000	usd
CY2023Q1	us-gaap	Nature Of Operations NatureOfOperations	Business<div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthpeak Properties, Inc., a Standard & Poor’s 500 company, is a Maryland corporation that is organized to qualify as a real estate investment trust (“REIT”) that, together with its consolidated entities (collectively, “Healthpeak” or the “Company”), invests primarily in real estate serving the healthcare industry in the United States (“U.S.”). Healthpeak® acquires, develops, owns, leases, and manages healthcare real estate. The Company’s diverse portfolio is comprised of investments in the following reportable healthcare segments: (i) life science; (ii) medical office; and (iii) continuing care retirement community (“CCRC”).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s corporate headquarters are in Denver, Colorado, and it has additional offices in California, Tennessee, and Massachusetts.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 7, 2023, Healthpeak Properties, Inc. announced its intent to complete an UPREIT reorganization. As part of the reorganization, the company formerly known as Healthpeak Properties, Inc. (“Old Healthpeak”) formed New Healthpeak, Inc. (“New Healthpeak”) as a wholly owned subsidiary, and New Healthpeak formed Healthpeak Merger Sub, Inc. (“Merger Sub”) as a wholly owned subsidiary. On February 10, 2023, Merger Sub merged with and into Old Healthpeak, with Old Healthpeak continuing as the surviving corporation and a wholly owned subsidiary of New Healthpeak (the “Merger”). In connection with the Merger, New Healthpeak changed its name to Healthpeak Properties, Inc. In connection with the UPREIT reorganization and immediately following the Merger, Old Healthpeak converted from a Maryland corporation to a Maryland limited liability company named Healthpeak OP, LLC (“Healthpeak OP”). Following the UPREIT reorganization, New Healthpeak’s business is conducted through Healthpeak OP and New Healthpeak does not have material assets or liabilities, other than through its investment in Healthpeak OP. This Quarterly Report on Form 10-Q pertains to the business and results of operations of Old Healthpeak through February 9, 2023 and of New Healthpeak from and including February 10, 2023, for the quarter ended March 31, 2023. For additional information on the UPREIT reorganization, see the Company’s Current Report on Form 8-K12B filed with the U.S. Securities and Exchange Commission (“SEC”) on February 10, 2023.</span></div>
CY2023Q1	peak	Commitments Development And Redevelopment Projects And Tenant Improvements Amount Increase Decrease CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovementsAmountIncreaseDecrease	-35000000	usd
CY2023Q1	peak	Commitments Development And Redevelopment Projects And Tenant Improvements CommitmentsDevelopmentAndRedevelopmentProjectsAndTenantImprovements	217000000	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2022Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2023Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	296217000	usd
CY2022Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	287292000	usd
CY2023Q1	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	96214000	usd
CY2022Q1	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	82858000	usd
CY2023Q1	us-gaap	Direct Financing Lease Interest Income DirectFinancingLeaseInterestIncome	0	usd
CY2022Q1	us-gaap	Direct Financing Lease Interest Income DirectFinancingLeaseInterestIncome	1168000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Lease Receivables ProceedsFromSaleOfLeaseReceivables	68000000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable	23000000	usd
CY2023Q1	peak	Properties With Direct Financing Leases Number PropertiesWithDirectFinancingLeasesNumber	0	property
CY2022Q4	peak	Properties With Direct Financing Leases Number PropertiesWithDirectFinancingLeasesNumber	0	property
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	706677000	usd
CY2023Q1	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	-1407000	usd
CY2022Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	-808000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	6152000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	8280000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	243149000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	374832000	usd
CY2022Q4	peak	Loans And Leases Receivable Remaining Commitments LoansAndLeasesReceivableRemainingCommitments	40000000	usd
CY2023Q1	peak	Loans And Leases Receivable Remaining Commitments LoansAndLeasesReceivableRemainingCommitments	40000000	usd
CY2023Q1	peak	Loans Receivable Extension Fee LoansReceivableExtensionFee	1000000	usd
CY2023Q1	peak	Finite Lived Intangible Liabilities Accumulated Amortization FiniteLivedIntangibleLiabilitiesAccumulatedAmortization	87227000	usd
CY2022Q4	peak	Finite Lived Intangible Liabilities Accumulated Amortization FiniteLivedIntangibleLiabilitiesAccumulatedAmortization	81271000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	8280000	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	1813000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	-171000	usd
CY2022	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	6534000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Sale And Reclassification To Held For Sale FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale	1957000	usd
CY2022	us-gaap	Financing Receivable Excluding Accrued Interest Sale And Reclassification To Held For Sale FinancingReceivableExcludingAccruedInterestSaleAndReclassificationToHeldForSale	67000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	6152000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	8280000	usd
CY2023Q1	peak	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Unfunded Loan Commitments FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments	700000	usd
CY2022Q4	peak	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Unfunded Loan Commitments FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestUnfundedLoanCommitments	800000	usd
CY2023Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	714679000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	767224000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	770285000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	375268000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	352224000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	391956000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	418061000	usd
CY2023Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P5Y
CY2022	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P5Y
CY2023Q1	peak	Finite Lived Intangible Liabilities Gross FiniteLivedIntangibleLiabilitiesGross	236831000	usd
CY2022Q4	peak	Finite Lived Intangible Liabilities Gross FiniteLivedIntangibleLiabilitiesGross	237464000	usd
CY2023Q1	peak	Finite Lived Intangible Liabilities Net FiniteLivedIntangibleLiabilitiesNet	149604000	usd
CY2022Q4	peak	Finite Lived Intangible Liabilities Net FiniteLivedIntangibleLiabilitiesNet	156193000	usd
CY2023Q1	peak	Acquired Finite Lived Intangible Liabilities Weighted Average Useful Life AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife	P7Y
CY2022	peak	Acquired Finite Lived Intangible Liabilities Weighted Average Useful Life AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife	P7Y
CY2023Q1	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	0	usd
CY2023Q1	peak	Finite Lived Intangible Liabilities Acquired FiniteLivedIntangibleLiabilitiesAcquired	0	usd
CY2022	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	7000000	usd
CY2022	peak	Finite Lived Intangible Liabilities Acquired FiniteLivedIntangibleLiabilitiesAcquired	6000000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	88765000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	7024000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	803209000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1450523000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	950366000	usd
CY2023Q1	peak	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	3200000000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	6499887000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	46009000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	6453878000	usd
CY2022Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.30
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.30
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.30
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.30
CY2022Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	500000000	usd
CY2022Q3	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	2100000	shares
CY2022Q3	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	2100000	shares
CY2022Q3	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	27.16
CY2022Q3	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	27.16
CY2022Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	56000000	usd
CY2022Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	56000000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	0	usd
CY2023Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	444000000	usd
CY2023Q1	us-gaap	Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax AociLossCashFlowHedgeCumulativeGainLossAfterTax	20668000	usd
CY2022Q4	us-gaap	Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax AociLossCashFlowHedgeCumulativeGainLossAfterTax	30145000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	1947000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	2011000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	18721000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	28134000	usd
CY2023Q1	peak	Number Of Plan Participants NumberOfPlanParticipants	1	plan_participant
CY2022	peak	Number Of Redeemable Noncontrolling Interest Redemptions NumberOfRedeemableNoncontrollingInterestRedemptions	1	interest
CY2023Q1	peak	Number Of Redeemable Noncontrolling Interests Redeemable Over Time NumberOfRedeemableNoncontrollingInterestsRedeemableOverTime	3	interest
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Equity Forward Agreements IncrementalCommonSharesAttributableToEquityForwardAgreements	0	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Equity Forward Agreements IncrementalCommonSharesAttributableToEquityForwardAgreements	0	shares
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	134507000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	75026000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	15555000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	3730000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	118952000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	71296000	usd
CY2023Q1	peak	Participating Securities Distributed And Undistributed Earnings Loss Basic And Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted	1254000	usd
CY2022Q1	peak	Participating Securities Distributed And Undistributed Earnings Loss Basic And Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted	1976000	usd
CY2023Q1	peak	Net Income Loss Continuing Operations Available To Common Stockholders Basic NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic	117698000	usd
CY2022Q1	peak	Net Income Loss Continuing Operations Available To Common Stockholders Basic NetIncomeLossContinuingOperationsAvailableToCommonStockholdersBasic	69320000	usd
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	usd
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	317000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	117698000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	117698000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	69637000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	69637000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	546842000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	539352000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	268000	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	234000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	547110000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	539586000	shares
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.22
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.13
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.22
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.13
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2023Q1	peak	Incremental Common Shares Attributable To Dilutive Effect Of Equity Awards IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards	1000000	shares
CY2022Q1	peak	Incremental Common Shares Attributable To Dilutive Effect Of Equity Awards IncrementalCommonSharesAttributableToDilutiveEffectOfEquityAwards	1000000	shares
CY2023Q1	peak	Numberof Facilities Ownedby Unconsolidated Joint Venture NumberofFacilitiesOwnedbyUnconsolidatedJointVenture	19	property
CY2023Q1	us-gaap	Revenues Revenues	525678000	usd
CY2023Q1	peak	Government Grant Income From Cares Act GovernmentGrantIncomeFromCARESAct	137000	usd
CY2023Q1	peak	Interest Income Excluded From Adjusted Net Operating Income From Continuing Operations InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations	6163000	usd
CY2023Q1	peak	Real Estate Revenues From Joint Venture Attributable To Parent RealEstateRevenuesFromJointVentureAttributableToParent	23256000	usd
CY2023Q1	peak	Real Estate Revenues From Joint Venture Government Grant Income RealEstateRevenuesFromJointVentureGovernmentGrantIncome	228000	usd
CY2023Q1	peak	Real Estate Revenues From Joint Venture Attributable To Noncontrolling Interest RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest	9106000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	223088000	usd
CY2023Q1	peak	Operating Expenses From Joint Venture Attributable To Parent Net OperatingExpensesFromJointVentureAttributableToParentNet	16493000	usd
CY2023Q1	peak	Operating Expenses From Joint Venture Attributable To Noncontrolling Interest OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest	2635000	usd
CY2023Q1	peak	Non Cash Adjustments To Net Operating Income From Continuing Operations NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations	-4624000	usd
CY2023Q1	peak	Adjusted Net Operating Income From Continuing Operations AdjustedNetOperatingIncomeFromContinuingOperations	292460000	usd
CY2023Q1	peak	Reconciliation Of Operating Profit Loss From Segments To Consolidated Non Cash Adjustments ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments	4624000	usd
CY2023Q1	us-gaap	Interest Income Operating InterestIncomeOperating	6163000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	47963000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	179225000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24547000	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2425000	usd
CY2023Q1	peak	Impairments And Allowance For Credit Loss Reserves ImpairmentsAndAllowanceForCreditLossReserves	-2213000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	81578000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	772000	usd
CY2023Q1	peak	Interest Income Excluded From Adjusted Government Grant Income From Continuing Operations InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations	-137000	usd
CY2023Q1	peak	Net Income Loss Joint Venture Partners Attributable To Parent NetIncomeLossJointVenturePartnersAttributableToParent	-6991000	usd
CY2023Q1	us-gaap	Noncontrolling Interest In Net Income Loss Joint Venture Partners Nonredeemable NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable	-6471000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	132993000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	302000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1816000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	134507000	usd
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	134507000	usd
CY2022Q1	us-gaap	Revenues Revenues	498372000	usd
CY2022Q1	peak	Government Grant Income From Cares Act GovernmentGrantIncomeFromCARESAct	6552000	usd
CY2022Q1	peak	Interest Income Excluded From Adjusted Net Operating Income From Continuing Operations InterestIncomeExcludedFromAdjustedNetOperatingIncomeFromContinuingOperations	5494000	usd
CY2022Q1	peak	Real Estate Revenues From Joint Venture Attributable To Parent RealEstateRevenuesFromJointVentureAttributableToParent	20208000	usd
CY2022Q1	peak	Real Estate Revenues From Joint Venture Government Grant Income RealEstateRevenuesFromJointVentureGovernmentGrantIncome	648000	usd
CY2022Q1	peak	Real Estate Revenues From Joint Venture Attributable To Noncontrolling Interest RealEstateRevenuesFromJointVentureAttributableToNoncontrollingInterest	8877000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	207247000	usd
CY2022Q1	peak	Operating Expenses From Joint Venture Attributable To Parent Net OperatingExpensesFromJointVentureAttributableToParentNet	14837000	usd
CY2022Q1	peak	Operating Expenses From Joint Venture Attributable To Noncontrolling Interest OperatingExpensesFromJointVentureAttributableToNoncontrollingInterest	2621000	usd
CY2022Q1	peak	Non Cash Adjustments To Net Operating Income From Continuing Operations NonCashAdjustmentsToNetOperatingIncomeFromContinuingOperations	-17666000	usd
CY2022Q1	peak	Adjusted Net Operating Income From Continuing Operations AdjustedNetOperatingIncomeFromContinuingOperations	274280000	usd
CY2022Q1	peak	Reconciliation Of Operating Profit Loss From Segments To Consolidated Non Cash Adjustments ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedNonCashAdjustments	17666000	usd
CY2022Q1	us-gaap	Interest Income Operating InterestIncomeOperating	5494000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	37586000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	177733000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23831000	usd
CY2022Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	296000	usd
CY2022Q1	peak	Impairments And Allowance For Credit Loss Reserves ImpairmentsAndAllowanceForCreditLossReserves	132000	usd
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	3856000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	18316000	usd
CY2022Q1	peak	Interest Income Excluded From Adjusted Government Grant Income From Continuing Operations InterestIncomeExcludedFromAdjustedGovernmentGrantIncomeFromContinuingOperations	-6552000	usd
CY2022Q1	peak	Net Income Loss Joint Venture Partners Attributable To Parent NetIncomeLossJointVenturePartnersAttributableToParent	-6019000	usd
CY2022Q1	us-gaap	Noncontrolling Interest In Net Income Loss Joint Venture Partners Nonredeemable NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable	-6256000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	73719000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	777000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2084000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	75026000	usd
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	317000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	75343000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	65367000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	58487000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	160000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-1947000	usd
CY2023Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	14093000	usd
CY2022Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	8305000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	80000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	179000	usd
CY2023Q1	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	161774000	usd
CY2022Q1	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	163277000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	72032000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	158287000	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	0	usd
CY2021Q4	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	7707000	usd
CY2022Q4	peak	Cash And Cash Equivalents Including Discontinued Operations Total CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal	72032000	usd
CY2021Q4	peak	Cash And Cash Equivalents Including Discontinued Operations Total CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal	165994000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	54802000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	53454000	usd
CY2022Q4	peak	Disposal Group Including Discontinued Operation Restricted Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents	0	usd
CY2021Q4	peak	Disposal Group Including Discontinued Operation Restricted Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents	0	usd
CY2022Q4	peak	Restricted Cash And Cash Equivalents Including Discontinued Operations Total RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal	54802000	usd
CY2021Q4	peak	Restricted Cash And Cash Equivalents Including Discontinued Operations Total RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal	53454000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	126834000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	211741000	usd
CY2022Q4	peak	Disposal Group Including Discontinued Operations Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2021Q4	peak	Disposal Group Including Discontinued Operations Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7707000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	126834000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	219448000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59235000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	89066000	usd
CY2023Q1	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	0	usd
CY2022Q1	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	7989000	usd
CY2023Q1	peak	Cash And Cash Equivalents Including Discontinued Operations Total CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal	59235000	usd
CY2022Q1	peak	Cash And Cash Equivalents Including Discontinued Operations Total CashAndCashEquivalentsIncludingDiscontinuedOperationsTotal	97055000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	57990000	usd
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	52103000	usd
CY2023Q1	peak	Disposal Group Including Discontinued Operation Restricted Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents	0	usd
CY2022Q1	peak	Disposal Group Including Discontinued Operation Restricted Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationRestrictedCashAndCashEquivalents	0	usd
CY2023Q1	peak	Restricted Cash And Cash Equivalents Including Discontinued Operations Total RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal	57990000	usd
CY2022Q1	peak	Restricted Cash And Cash Equivalents Including Discontinued Operations Total RestrictedCashAndCashEquivalentsIncludingDiscontinuedOperationsTotal	52103000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	117225000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	141169000	usd
CY2023Q1	peak	Disposal Group Including Discontinued Operations Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2022Q1	peak	Disposal Group Including Discontinued Operations Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents DisposalGroupIncludingDiscontinuedOperationsCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7989000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	117225000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	149158000	usd
CY2023Q1	us-gaap	Asset At Fair Value Changes In Fair Value Resulting From Changes In Assumptions AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions	22000000	usd
CY2023Q1	peak	Refundable Entrance Fees Current And Noncurrent RefundableEntranceFeesCurrentAndNoncurrent	264065000	usd
CY2022Q4	peak	Refundable Entrance Fees Current And Noncurrent RefundableEntranceFeesCurrentAndNoncurrent	268972000	usd
CY2023Q1	us-gaap	Construction Payable Current And Noncurrent ConstructionPayableCurrentAndNoncurrent	161774000	usd
CY2022Q4	us-gaap	Construction Payable Current And Noncurrent ConstructionPayableCurrentAndNoncurrent	178626000	usd
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	39065000	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	59291000	usd
CY2023Q1	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	224090000	usd
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	265596000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	688994000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	772485000	usd
CY2023Q1	us-gaap	Severance Costs1 SeveranceCosts1	12000000	usd
CY2022	us-gaap	Severance Costs1 SeveranceCosts1	15000000	usd
CY2023Q1	peak	Nonrefundable Entrance Fees NonrefundableEntranceFees	527476000	usd
CY2022Q4	peak	Nonrefundable Entrance Fees NonrefundableEntranceFees	518573000	usd
CY2023Q1	peak	Other Deferred Revenue OtherDeferredRevenue	350968000	usd
CY2022Q4	peak	Other Deferred Revenue OtherDeferredRevenue	325503000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	878444000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	844076000	usd
CY2023Q1	peak	Proceeds From Collection Of Nonrefundable Entrance Fees ProceedsFromCollectionOfNonrefundableEntranceFees	29000000	usd
CY2022Q1	peak	Proceeds From Collection Of Nonrefundable Entrance Fees ProceedsFromCollectionOfNonrefundableEntranceFees	21000000	usd
CY2023Q1	peak	Amortization Of Nonrefundable Entrance Fee AmortizationOfNonrefundableEntranceFee	20000000	usd
CY2022Q1	peak	Amortization Of Nonrefundable Entrance Fee AmortizationOfNonrefundableEntranceFee	19000000	usd
CY2023Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	13000000	usd
CY2022Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	9000000	usd

Files In Submission

Name	View Source	Status
peak-20230331_lab.xml	Edgar Link	unprocessable
peak-20230331_pre.xml	Edgar Link	unprocessable
0001628280-23-014190-index-headers.html	Edgar Link	pending
0001628280-23-014190-index.html	Edgar Link	pending
0001628280-23-014190.txt	Edgar Link	pending
0001628280-23-014190-xbrl.zip	Edgar Link	pending
ex101003312023.htm	Edgar Link	pending
ex101103312023.htm	Edgar Link	pending
ex101203312023.htm	Edgar Link	pending
ex101303312023.htm	Edgar Link	pending
ex101403312023.htm	Edgar Link	pending
ex101503312023.htm	Edgar Link	pending
ex101603312023.htm	Edgar Link	pending
ex10703312023.htm	Edgar Link	pending
ex10803312023.htm	Edgar Link	pending
ex10903312023.htm	Edgar Link	pending
ex22103312023.htm	Edgar Link	pending
ex31103312023.htm	Edgar Link	pending
ex31203312023.htm	Edgar Link	pending
ex32103312023.htm	Edgar Link	pending
ex32203312023.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
image_0a.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
peak-20230331.htm	Edgar Link	pending
peak-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
peak-20230331_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
peak-20230331_cal.xml	Edgar Link	unprocessable
peak-20230331_htm.xml	Edgar Link	completed
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DOC
HEALTHPEAK PROPERTIES, INC. Stock $doc

2023 Q2 Form 10-Q Financial Statement

#000162828023014190 Filed on April 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DOC HEALTHPEAK PROPERTIES, INC. Stock $doc

2023 Q2 Form 10-Q Financial Statement

#000162828023014190 Filed on April 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DOC
HEALTHPEAK PROPERTIES, INC. Stock $doc